fr Sign in Create account

BRISTOL-MYERS SQUIBB COMPANY

United States· USD

BMYRetail (specialty)5 years

Latest published accounts SEC EDGAR All listed in this sector

FY 2025, amounts converted into euros

Revenue: 41.69 bn EUR
EBITDA: 16.04 bn EUR
Operating income: 13.01 bn EUR
Net income: 6.1 bn EUR

Description

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. 69,1% du CA est réalisé aux Etats-Unis. Nombre d'employés: 32 500

Source: Argos company profile.

Analyst consensus

Analyst rating: 6.2/10
Recommendation: Accumulate; 29 analysts
Average target: 63.04 USD; +2.6 % from the last price
Last price: 61.45 USD; close of 01/10/2026

Key figures

Employees: 32,500
Largest business: Pharmaceuticals100 % of revenue
Largest region: United States69 % of revenue
Head office: Princeton, United States

Identity

Ticker: BMY
ISIN: US1101221083
Country: United States
Region: Amérique du Nord
Sector: Retail (specialty)
Sector group: Retail & Distribution
Sub-sector: Pharmacies - Others
Fiscal year end: Décembre
Reporting currency: USD
Trading currency: USD
Address: Route 206

Source: SEC EDGAR. Accounts published by the company, restated against a single chart of accounts and converted into euros by Argos; verify on the official filing for any critical use.